Evidence from receptor blockade and GLP-1R gene knockdown experiments confirmed that the spinal cord is a primary site mediating exenatide-induced antinociception [24]
Semaglutide, another modified analog of human GLP-1, is resistant to DPP-4 degradation, which enables a once-weekly injection (Lau et al., 2015)
The availability of Replenza GLP-1 Support can fluctuate, potentially leading to difficulties in obtaining it regularly
is an associate editor of the Journal of Prevention of Alzheimers Disease and Alzheimers and Dementia: Diagnosis, Assessment and Disease Monitoring
(1) Huang T, Zhang K, Sun L, Xue X, Zhang C, Shu Z, Mu N, Gu J, Zhang W, Wang Y, Zhang Y, Zhang W